Everest Financial Group LLC
Source: SEC Form 13F · as of Mar 2026Everest Financial Group LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $14.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$14.3M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 33,965 | $9.2M |
| MRKMerck & Co., Inc. | 10,475 | $1.3M |
| ABBVAbbVie Inc. | 3,426 | $745K |
| LLYELI LILLY & Co | 643 | $592K |
| AMGNAMGEN INC | 1,505 | $530K |
| JNJJOHNSON & JOHNSON | 2,118 | $518K |
| GMOptec International, Inc. | 5,504 | $410K |
| GILDGILEAD SCIENCES, INC. | 2,294 | $320K |
| ABTABBOTT LABORATORIES | 2,748 | $282K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,081 | $225K |
| NVONovo Nordisk A/S | 6,124 | $225K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.